Lexington, KY, United States of America

Do-Min Lee

This inventor holds 1 USPTO granted patent. Top assignee: University of Kentucky Research Foundation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Do-Min Lee. Retrieved from https://idiyas.com/inventor/do-min-lee-fiseiydi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Do-Min Lee: Innovator in Proteasome Inhibitors

Introduction

Do-Min Lee is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of biochemistry, particularly in the development of proteasome inhibitors. His work has implications for various therapeutic applications, showcasing the potential of his innovations.

Latest Patents

Do-Min Lee holds one patent related to proteasome inhibitors. The patent describes compounds of formula (I) that are useful for inhibiting a proteasome in a cell. The patent also includes pharmaceutical compositions and methods of use, highlighting the practical applications of his research.

Career Highlights

Do-Min Lee is affiliated with the University of Kentucky Research Foundation, where he conducts his research. His work at this institution has allowed him to explore innovative solutions in the realm of proteasome inhibition, contributing to advancements in medical science.

Collaborations

Do-Min Lee has collaborated with notable colleagues, including Kyung-Bo Kim and Vinod Kasam. These partnerships have likely enhanced the scope and impact of his research, fostering a collaborative environment for innovation.

Conclusion

Do-Min Lee's contributions to the field of proteasome inhibitors exemplify the importance of innovation in medical research. His work not only advances scientific understanding but also holds promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…